| Pharmaceutical Information |
| Drug Name |
Semaxanib |
| Drug ID |
BADD_D02007 |
| Description |
Not Available |
| Indications and Usage |
Investigated for use/treatment in colorectal cancer and lung cancer. |
| Marketing Status |
investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB06436
|
| KEGG ID |
D05819
|
| MeSH ID |
C116890
|
| PubChem ID |
5329098
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
71IA9S35AJ
|
| Synonyms |
Semaxinib | SU 5416 | SU5416 | Sugen 5416 | SU-5416 | 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one |
|
| Chemical Information |
| Molecular Formula |
C15H14N2O |
| CAS Registry Number |
194413-58-6 |
| SMILES |
CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
